Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease
NCT01559142
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Interventions
DRUG:
Infliximab with azathioprine (IIFX + AZA)
DRUG:
Infliximab (IFX alone)
Sponsor
Children's Memorial Health Institute, Poland